These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 19546557

  • 1. Systemic therapies in hepatocellular carcinoma.
    Wörns MA, Weinmann A, Schuchmann M, Galle PR.
    Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
    [Abstract] [Full Text] [Related]

  • 2. Targeted therapy of hepatocellular cancer.
    Wysocki PJ.
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [Abstract] [Full Text] [Related]

  • 3. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
    Zender L, Kubicka S.
    Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656
    [Abstract] [Full Text] [Related]

  • 4. Future perspectives in hepatocellular carcinoma.
    Wörns MA, Galle PR.
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S302-9. PubMed ID: 20547319
    [Abstract] [Full Text] [Related]

  • 5. Novel inhibitors in development for hepatocellular carcinoma.
    Wörns MA, Galle PR.
    Expert Opin Investig Drugs; 2010 May; 19(5):615-29. PubMed ID: 20374038
    [Abstract] [Full Text] [Related]

  • 6. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
    Zhu AX.
    Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
    [Abstract] [Full Text] [Related]

  • 7. Molecularly targeted therapy in hepatocellular carcinoma.
    Huynh H.
    Biochem Pharmacol; 2010 Sep 01; 80(5):550-60. PubMed ID: 20371362
    [Abstract] [Full Text] [Related]

  • 8. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW, Poon RT.
    Oncology; 2007 Sep 01; 72 Suppl 1():30-44. PubMed ID: 18087180
    [Abstract] [Full Text] [Related]

  • 9. Growth factors as therapeutic targets in HCC.
    Furuse J.
    Crit Rev Oncol Hematol; 2008 Jul 01; 67(1):8-15. PubMed ID: 18434184
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B, Tovar V, Chiang D, Villanueva A, Llovet JM.
    Curr Opin Gastroenterol; 2009 May 01; 25(3):186-94. PubMed ID: 19387255
    [Abstract] [Full Text] [Related]

  • 11. [Hepatocellular carcinoma].
    Kondo S, Ueno H, Morizane C, Okusaka T.
    Gan To Kagaku Ryoho; 2010 Jul 01; 37(7):1219-23. PubMed ID: 20647702
    [Abstract] [Full Text] [Related]

  • 12. Systemic therapy of hepatocellular carcinoma: are we making progress?
    Roxburgh P, Evans TR.
    Adv Ther; 2008 Nov 01; 25(11):1089-104. PubMed ID: 18972075
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA, Weinmann A, Pfingst K, Schulte-Sasse C, Messow CM, Schulze-Bergkamen H, Teufel A, Schuchmann M, Kanzler S, Düber C, Otto G, Galle PR.
    J Clin Gastroenterol; 2009 Nov 01; 43(5):489-95. PubMed ID: 19247201
    [Abstract] [Full Text] [Related]

  • 14. Tyrosine kinase inhibitors to treat liver cancer.
    Huynh H.
    Expert Opin Emerg Drugs; 2010 Mar 01; 15(1):13-26. PubMed ID: 20128706
    [Abstract] [Full Text] [Related]

  • 15. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M, Biasi F, Feo F, Pascale RM.
    Mol Aspects Med; 2010 Apr 01; 31(2):179-93. PubMed ID: 20176048
    [Abstract] [Full Text] [Related]

  • 16. The present and the future landscape of treatment of advanced hepatocellular carcinoma.
    Rimassa L, Santoro A.
    Dig Liver Dis; 2010 Jul 01; 42 Suppl 3():S273-80. PubMed ID: 20547314
    [Abstract] [Full Text] [Related]

  • 17. Emerging targeted strategies in advanced hepatocellular carcinoma.
    Finn RS.
    Semin Liver Dis; 2013 Feb 01; 33 Suppl 1():S11-9. PubMed ID: 23457035
    [Abstract] [Full Text] [Related]

  • 18. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
    Rimassa L, Santoro A.
    Expert Rev Anticancer Ther; 2009 Jun 01; 9(6):739-45. PubMed ID: 19496710
    [Abstract] [Full Text] [Related]

  • 19. Systemic chemotherapy of hepatocellular carcinoma--Korean experience.
    Lee HC.
    Oncology; 2008 Jun 01; 75 Suppl 1():114-8. PubMed ID: 19092280
    [Abstract] [Full Text] [Related]

  • 20. Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?
    Finn RS.
    Clin Cancer Res; 2010 Jan 15; 16(2):390-7. PubMed ID: 20068087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.